Portage Biotech Inc (NASDAQ:PRTG)
| 7.19 Delayed Data As of Dec 02 |  -0.25 / -3.36%Today’s Change | 4.62 Today|||52-Week Range 14.10 | -32.99% Year-to-Date |
Latest PRTG News | Press Releases
| How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160% Dec 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.44 |
| Today’s open | 7.21 |
| Day’s range | 7.19 - 7.21 |
| Volume | 302 |
| Average volume (3 months) | 15,012 |
| Market cap | -- |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | +4.28% |
| Earnings growth (this year) | +20.93% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PSNLPersonalis Inc | +0.15 | +5.49% |
| INMBINmune Bio Inc | -0.16 | -2.30% |
| VBIVVBI Vaccines Inc | -0.01 | -2.48% |
| IFRXInflaRx NV | -0.07 | -2.60% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | February 24, 2023 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$16.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
